CHRISTINA FU
Partner·Hong Kong
CHRISTINA FU
Partner·Hong Kong
-
CHRISTINA FU
Partner·Hong Kong
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
CHRISTINA FU SPECIALIZES IN CAPITAL MARKETS, FOREIGN INVESTMENT, MERGERS AND ACQUISITIONS, CORPORATE GOVERNANCE AND COMPLIANCE MATTERS, CONTENTIOUS REGULATORY AND ANTI-MONEY LAUNDERING WORK.
Education
Manchester Metropolitan University, UK, LL.B
Australian National University, GDLP
The University of Hong Kong, SPACE, DLS
South China University of Technology Certificate in Chinese Legal System
Professional Qualification
Admitted to practice in Hong Kong SAR
Admitted to practice in New South Wales (Australia)
Admitted to practice in New Zealand (non-practicing)
Certified Anti-money laundering Specialist (CAMS)
Certified Professional Forensic Accountant
Professional Background
Prior to joining Fangda Partners, Christina was with two prominent international firms, namely Freshfields Bruckhaus Deringer and Herbert Smith Freehills.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Represented several SFC Type 6 licensed corporations in responding to the SFC's enquiries during its annual review of sponsor’s due diligence work assessment for IPO application, including negligence in conducting due diligence, disclosure or provision of false and misleading information and violations of the SFC’s code of conduct.
- Represented a SFC Type 6 licensed corporation in responding to the SFC’s enquiries under section 6(1) of the Securities and Futures (Stock Market Listing) Rules regarding provision of false or misleading information and violations of disclosure obligations during the IPO process.
- Represented several Hong Kong listed companies in their trading resumption application and/or their replies to the Hong Kong Stock Exchange's enquiry on whether the company has a sufficient level of operations to comply with Rule 13.24(1) of the Main Board Listing Rules.
- Advised several Hong Kong listed companies on investigation conducted by the Hong Kong Accounting and Financial Reporting Council against its auditors/former auditors pertaining to adjustments, errors, omissions and/or misstatements in financial statements.
- Represented the audit committee of several Hong Kong listed companies in connection with the enquiries from the Hong Kong Accounting and Financial Reporting Council relating to change in auditors.
- Represented the special committee of several Hong Kong listed companies as their legal advisors in conducting self-investigation requested by auditors and/or forensic investigation requested by regulators, including fund misappropriation, questionable procurement processes, suspected manipulation of business revenue, suspicious money lending to external parties and internal control system
- Represented a director of a Hong Kong listed company in responding to an investigation by the Hong Kong Stock Exchange regarding a substantial undisclosed investment which was alleged to have breached the Hong Kong Listing Rules.
- Represented a licensed corporation engaged in virtual currencies business in response to compliance enquiries from the SFC.
- Advised several foreign corporations on setting up their anti-money laundering system and policies in Hong Kong.
- Advised Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co., , a H share company listed on the Hong Kong Stock Exchange (stock code: 1349.HK) on its A-share issuance of on STAR Market of the Shanghai Stock Exchange (stock code: 688505.SH).
- Advised Shandong Fengxiang Co., Ltd. (stock code: 9977) on its H shares global offering listing on the Main Board of the Hong Kong Stock Exchange. The sole sponsor was Southwest Securities; the joint global coordinators were ABCI Capital, China Galaxy International, China Securities (International) Corporate Finance, Haitong International and Southwest Securities Brokerage.
- Advised Ant Group Co., Ltd. (stock code: 6688) on its proposed dual listing on the STAR Board of the Shanghai Stock Exchange and the Main Board of the Hong Kong Stock Exchange and act as the Special Consultant as to Hong Kong Law
- Advised Sun Car Insurance Agency Co., Ltd. (stock code: 1879) on its proposed H shares global offering and listing on the Main Board of the Hong Kong Stock Exchange. Sun Car was quoted on NEEQ and sought for dual listing of its H shares on the Hong Kong Stock Exchange. The joint sponsors were China Galaxy International and CICC.
- Advised Haitong International as one of the underwriters on a rights issue of Carnival Group International Holdings Limited (stock code: 996).
- Advised Octal Capital as sole sponsor on a share offer of Yuk Wing Group Holdings Limited (stock code: 1536) and its listing on the Main Board of the Hong Kong Stock Exchange.
- Advised Shanghai Dasheng Agriculture Finance Technology Co., Ltd. (stock code: 1103) on its subscription of domestic shares and placing of H shares and its rights issue of domestic and H rights shares.
- Advised HSBC as the sole sponsor, and HSBC, BOCI, J.P. Morgan and Standard Chartered as placing agents on an acquisition constitutes a reverse takeover involving a deemed new listing on the Main Board of the Hong Kong Stock Exchange and a share placing of Joy City Property Limited (previously known as COFCO Land Holdings Limited) (stock code: 207).
- Advised Shui On Land Limited (stock code: 272) on its rights issue. The joint underwriters were BNP, Standard Chartered and UOB.
- Advised Esprit Holdings Limited (stock code: 330) on its rights issue. The joint underwriters were HSBC and UBS.
- Advised BOCI as the sole placing agent on a RMB-denominated share placing on the Hong Kong Stock Exchange under a dual-counter trading arrangement by Hopewell Highway Infrastructure Limited (stock code: 00737(HK$) / 80737(RMB)).
- Advised Sunshine Oilsands Ltd. (stock code: 2012) on its global offering and listing on the Main Board of Hong Kong Stock Exchange. Sunshine Oilsands is the first Alberta incorporated company to list on the Hong Kong Stock Exchange. The joint sponsors were Bank of China International, Deutsche Bank and Morgan Stanley.
- Advised SBI Holdings, Inc. (stock code: 6488) on its Hong Kong depository receipts offering and secondary listing on the Main Board of the Hong Kong Stock Exchange. SBI is the first Japanese company to list on the Hong Kong Stock Exchange. The sole sponsor was Daiwa Capital.
- Advised AIA Group Limited (stock code: 1299) on its global offering and listing on the Main Board of the Hong Kong Stock Exchange. The joint sponsors were Citigroup, Deutsche Bank, Goldman Sachs and Morgan Stanley.
- Advised Agricultural Bank of China Limited (stock code: 1288) on its A+H shares global offering and listing on the Main Board of the Hong Kong Stock Exchange. The joint sponsors were CICC, Goldman Sachs, Morgan Stanley, Deutsche Bank, J.P. Morgan, Macquarie and ABCI.
- Advised BaWang International (Group) Holding Limited (stock code: 1338) on its global offering and listing on the Main Board of the Hong Kong Stock Exchange. The joint sponsors were HSBC and Morgan Stanley.
- Advised CICC and Macquarie as joint sponsors on a A+H shares global offering of China South Locomotive & Rolling Stock Corporation Limited (currently CRRC Corporation Limited after its merger with China CNR Corporation Limited) (stock code: 1766) and its listing on the Main Board of the Hong Kong Stock Exchange.
- Advised J.P. Morgan and UBS as joint sponsors on a US$285 million global offering of Xtep International Holdings Limited (stock code: 1368) and its listing on the Main Board of the Hong Kong Stock Exchange.
- Advised Alibaba Pictures Group Limited (stock code: 1060)’s acquisition of online streaming business (involving consideration share issuance).
- Advised Viva Biotech Holdings (stock code: 1873)’s disposal of companies engaged in CRO business to investors including Temasek and HLC fund.
- Advised China Telecom Corporation Limited (stock code: 728) on its acquisition of CDMA network assets and associated liabilities from China Telecommunications Corporation. The financial advisor was UBS.
- Advised G-Resources Group Limited (stock code: 1051)'s purchase of limited partnership interests in three funds and acquisition of Lippo Securities group.
- Agricultural Bank of China Limited (stock code: 1288)
- Shandong International Trust Co., Ltd. (stock code: 1697)
- China Development Bank Financial Leasing Co., Ltd. (stock code: 1606)
- Shanghai MicroPort MedBot (Group) Co., Ltd. (stock code: 2252)
- Shandong Fengxiang Co., Ltd. (stock code: 9997)
- G-Resources Group Limited (stock code: 1051)
- China Telecom Corporation Limited (stock code: 728)
- Sinopec Shanghai Petrochemical Company Limited (stock code: 338), etc.
